Chemomab Therapeutics (CMMB) Receivables - Net (2017 - 2019)
Chemomab Therapeutics' (CMMB) quarterly Receivables - Net came in at $408000.0 in Q4 2019, down 88.01% YoY from $3.4 million in Q4 2018, and down 66.99% on a QoQ basis from $1.2 million in Q3 2019.
Chemomab Therapeutics (CMMB) Receivables - Net (2017 - 2019) Analysis & Trends
Chemomab Therapeutics (CMMB) has 3 years of Receivables - Net data on file, last reported at $408000.0 in Q4 2019.
- Quarterly Receivables - Net fell 88.01% year-over-year to $408000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $408000.0 (down 88.01% YoY) and the FY2019 annual result came in at $408000.0, down 88.01% from the prior year.
- Receivables - Net eased to $408000.0 in Q4 2019, from $1.2 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $3.4 million in Q4 2018 to a low of $400000.0 in Q4 2017.
- A 3-year average of $1.3 million and a median of $885000.0 in 2019 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2018 — Receivables - Net jumped 750.75% — and 2019, when it sank 88.01%.
- Tracing CMMB's Receivables - Net over 3 years: stood at $400000.0 in 2017, then jumped by 750.75% to $3.4 million in 2018, then slumped by 88.01% to $408000.0 in 2019.
- The last three Receivables - Net figures came in at $408000.0 (Q4 2019), $1.2 million (Q3 2019), and $885000.0 (Q2 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Chemomab Therapeutics | 13.62 Mn | 3.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 408,000.00 |
| Dec 31, 2019 | 408,000.00 |
| Sep 30, 2019 | 1.24 Mn |
| Sep 30, 2019 | 1.24 Mn |
| Jun 30, 2019 | 885,000.00 |
| Jun 30, 2019 | 885,000.00 |
| Dec 31, 2018 | 3.40 Mn |
| Dec 31, 2018 | 3.40 Mn |
| Dec 31, 2017 | 400,000.00 |
| Dec 31, 2017 | 400,000.00 |